Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* written informed consent~* ambulatory male and female patients 18 years of age or older~* summarised score of signs and symptoms of blepharitis of 15 or more at baseline~Exclusion Criteria:~* different ocular conditions~* different system conditions~* several concomitant medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Posiformin 2 % (Type: ACTIVE_COMPARATOR): Eye ointment applied to the eye lid
- Placebo (Type: PLACEBO_COMPARATOR): corresponding vehicle, eye ointment applied to the eye lid

Based on this trial design, predict the completion outcome and termination type (if applicable).